Histopathological assessment of multidrug resistance in gastric cancer: Expression of P-glycoprotein, multidrug resistance-associated protein, and lung-resistance protein

Surgery Today

Volumn 29, Issue 5, 1999, Pages 401-406

  Alexander, Delamou ^a   Yamamoto, Tetsu ^a   Kato, Shizuo ^a   Kasai, Shinichi ^a  

^a ASAHIKAWA MEDICAL COLLEGE   (Japan)

Author keywords

Immunohistochemistry; Multidrug resistance; Proliferative cell nuclear antigen; Stomach cancer

Indexed keywords

GLYCOPROTEIN P; LUNG RESISTANCE PROTEIN; MULTIDRUG RESISTANCE PROTEIN; TUMOR ANTIGEN;

ADJUVANT CHEMOTHERAPY; ADULT; AGED; ANTIGEN DETECTION; ARTICLE; CANCER GRADING; CANCER RESISTANCE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MALE; MULTIDRUG RESISTANCE; PROTEIN DETERMINATION; PROTEIN EXPRESSION; STOMACH ADENOCARCINOMA; STOMACH LYMPHOMA; TUMOR DIFFERENTIATION;

EID: 0033017449     PISSN: 09411291     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02483030     Document Type: Article

References (38)

1. Charles SF (1997) Chemotherapy for advanced gastric cancer: where do we stand? J Clin Oncol 15:3299-3300
2. Charles SF, Robert JM (1995) Gastric carcinoma. N Engl J Med 333:32-41
3. Cunningham D (1988) Gastric cancer. The recognition of a chemosensitive tumour. Br J Cancer 58:695-699
4. Neri B, de Leonardis V, Romano S, Andreoli F, Pernice LM, Bruno L, Borrelli D, Valeri A, Fabbroni S, Intini C, Cini G (1996) Adjuvant chemotherapy after gastric resection in node-positive cancer patients: a multicentre randomised study. Br J Cancer 73:549-552
5. Hermans J, Bonenkamp JJ, Boon MC, Bunt AM, Ohyama S, Sasako M, van de Velde (1993) Adjuvant therapy after curative resection for gastric cancer: Meta-analysis of randomized trials. J Clin Oncol 11:1441-1447
6. Douglass HO Jr (1989) Gastric cancer. Current status of adjuvant therapy. Oncology 3:61-66
7. Allum WH, Hallissey MT, Ward LC, Hockey MS (1989) A controlled, prospective, randomised trial of adjuvant chemotherapy or radiotherapy in resectable gastric cancer: interim report. Br J Cancer 60:739-744
8. Coombes RC, Schein PS, Chilvers CE, Wils J, Beretta G, Bliss JM, Rutten A, Amadori D, Cortes-Funes H, Villar-Grimdt A (1990) A randomized trial comparing adjuvant fluorouracil, doxorubicin and mitomycin with no treatment in operable gastric cancer. International collaborative cancer group. J Clin Oncol 8:1362-1369
9. Lise M, Nitti D, Marchet A, Sahmoud T, Buyse M, Duex N, Fiorentino M, Dos Santos JG, Labianca R, Rougier P, Gignoux M (1995) Final results of a phase III clinical trial of adjuvant chemotherapy with the modified fluorouracil, doxorubicin, and mitomycin regimen in resectable gastric cancer. J Clin Oncol 13:2757-2763
10. Bleiberg H, Gerard B, Deguiral P (1992) Adjuvant therapy in resectable gastric cancer. Br J Cancer 66:987-991
11. Pastan I, Gottesman M (1987) Multiple drug resistance in human cancer. N Engl J Med 316:1388-1393
12. Endicott JA, Ling V (1989) The biochemistry of P-glycoprotein mediated multidrug resistance. Annu Rev Biochem 58:137-171
13. Kaye SB (1988) The multidrug resistance phenotype. Br J Cancer 58:691-694
14. Cornwell MM, Tsuruo T, Gottesman MM, Pastan I (1987) ATP-binding properties of P-glycoprotein from multidrug resistant KB cells. FASEB J 1:51-54
15. Gottesman MM, Pastan I (1988) The multidrug transporter, a double-edged sword. J Biol Chem 263:12163-12166
16. Fojo AT, Ueda K, Slamon DJ, Poplack DG, Gottesman MM, Pastan I (1987) Expression of a multidrug-resistance gene in human tumors and tissues. Proc Natl Acad Sci USA 84:265-269
17. Scheper RJ, Broxterman HJ, Scheffer GL, Meijer CJLM, Pinedo HM (1992) Drug-transporter proteins in clinical multidrug resistance. Clin Chim Acta 206:25-32
18. Grant CE, Valdimarsson G, Hipfner DR, Almquist KC, Cole SP, Deeley RG (1994) Overexpression of multidrug resistance-associated protein (MRP) increases resistance to natural product drugs. Cancer Res 54:357-361
19. Cole SP, Bhardwaj G, Gerlach JH, Mackie JE, Grant CE, Almquist KC, Stewart AJ, Kurz EU, Duncan AM, Deeley RG (1992) Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line. Science 258:1650-1654
20. Krishnamachary N, Center MS (1993) The MRP gene associated with a non-P-glycoprotein multidrug resistance encodes a 190-KDa membrane bound glycoprotein. Cancer Res 53:3658-3661
21. Schadendorf D, Makki A, Stahr C, Van Dyck A, Wanner R, Scheffer GL, Flens MJ, Scheper R, Henz BM (1995) Membrane transport proteins associated with drug resistance expressed in human melanoma. Am J Pathol 147:1545-1552
22. Zaman GJ, Flens MJ, van Leusden MR, de Haas M, Mulder HS, Lankelma J, Pinedo HM, Scheper RJ, Baas F, Broxterman HJ, Borst P (1994) The human multidrug resistance-associated protein (MRP) is a plasma membrane drug efflux pump. Proc Natl Acad Sci USA 91:8822-8826
23. Scheper RJ, Broxterman HJ, Scheffer GL, Kaaijk P, Dalton WS, van Heijningen TH, van Kalken CK, Slovak ML, de Vries EG, van der Valk P, Meijer CJ, Pinedo HM (1993) Overexpression of a Mr 110000 vesicular protein in non-P-glycoprotein mediated multidrug-resistance. Cancer Res 53:1475-1479
24. Scheffer GL, Wijngaard PL, Flens MJ, Izquierdo MA, Slovak ML, Pinedo HM, Meijer CJ, Clevers HC, Scheper RJ (1995) The drug resistance relatted protein LRP is the human major vault protein. Nat Med 1:578-582
25. Noonan KE, Beck C, Holzmayer TA, Chin JE, Wunder JS, Andrulis IL, Gazdar AF, Willman CL, Griffith B, Von Hoff DD, Roninson IB (1990) Quantitative analysis of MDR-1 (multi drug resistance) gene expression in human tumors by polymerase chain reaction. Proc Natl Acad Sci USA 87:7160-7164
26. Verrelle P, Meissonnier F, Feillel V, Dionet C, Kwiatkowski F, Plagne R, Chassagne J (1991) Clinical relevance of immuno-histochemical detection of multidrug resistance P-glycoprotein in breast carcinoma. J Natl Cancer Inst 83:111-116
27. Hipfner DR, Gauldie SD, Deeley RG, Cole SP (1994) Detection of the Mr 190000 multidrug resistance protein, MRP with monoclonal antibodies. Cancer Res 54:5788-5792
28. Flens MJ, Izquierdo MA, Scheffer GL, Fritz JM, Meijer CJ, Scheper RJ, Zaman GJ (1994) Immunochemical detection of the multidrug resistance associated protein MRP in human multidrug resistant tumor cells by monoclonal antibodies. Cancer Res 54:4557-4563
29. Yuen AR, Sikic BI (1994) Multidrug resistance in lymphomas. J Clin Oncol 12:2453-2459
30. Mizoguchi T, Yamada K, Furukawa T, Hidaka K, Hisatsugu T, Shimazu H, Tsuruo T, SumizawaT, Akiyama S (1990) Expression of the MDR-1 gene in human gastric and colorectal carcinomas. J Natl Cancer Inst 82:1679-1683
31. Maehara Y, Anai H, Kusumoto H, Sugimachi K (1987) Poorly differentiated human gastric carcinoma is more sensitive to anti-tumor drugs than well differentiated carcinoma. Eur J Surg Oncol 13:203-206
32. Endo K, Maehara Y, Ishiyoshi Y, Kusumoto T, Sakaguchi Y, Ohno S, Sugimachi K (1996) Multidrug resistance-associated protein expression in clinical gastric carcinoma. Cancer 77:1681-1687
33. Izquierdo MA, van der Zee AG, Vermorken JB, van der Valk P, Belien JA, Giaccone G, Scheffer GL, Flens MJ, Pinedo HM, Kenemans P, Meijer CJ, de Vries EG, Scheper RJ (1995) Drug resistance-associated marker Lrp for prediction of response to chemotherapy and prognoses in advanced ovarian carcinoma. J Natl Cancer Inst 87:1230-1237
34. Ota E, Abe Y, Oshika Y, Ozeki Y, Iwasaki M, Inoue H, Yamazaki H, Ueyama Y, Takagi K, Ogata T, Tamaoki N, Nakamura M (1995) Expression of the multidrug resistance-associated protein (MRP) gene in non-small-cell lung cancer. Br J Cancer 72:550-554
35. Jain S, Filipe MI, Hall PA, Waseem N, Lane DP, Levison DA (1991) Prognostic value of proliferating cell nuclear antigen in gastric carcinoma. J Clin Pathol 44:655-659
36. Shen DW, Fojo A, Chin JE, Roninson IB, Richert N, Pastan I, Gottesman MM (1986) Human multidrug-resistant cell lines: increased mdr1 expression can precede gene amplification. Science 232:643-645
37. Kakehi Y, Kanamaru H, Yoshida O, Ohkubo H, Nakanishi S, Gottesman MM, Pastan I (1988) Measurement of multidrug-resistance messenger RNA in urogenital cancers; elevated expression in renal cell carcinoma is associated with intrinsic drug resistance. J Urol 139:862-865
38. Slovak ML, Ho JP, Bhardwaj G, Kurz EU, Deeley RG, Cole SP (1993) Localization of a novel multidrug resistance-associated gene in the HT 1080/DR4 and H69AR human tumor cell lines. Cancer Res 53:3221-3225